-
Djokovic confirmed for ATP Finals, says Italian federation boss
-
Trent should be remembered for 'great' Liverpool moments, says Slot
-
Stock markets diverge despite boost from AI deals
-
Prince William awed by Rio on climate-focused trip to Brazil
-
Violence in Sudan's El-Fasher could be war crimes, says top court
-
Rybakina downs Swiatek in WTA Finals
-
Turkey, Muslim allies say Palestinian self-rule key to Gaza future
-
Tens of thousands shelter as typhoon slams into Philippines
-
Stock markets rise as tech sector buoyed by fresh AI deal
-
Vitinha says PSG-Bayern Champions League clash will show who's 'best'
-
Arsenal: The unstoppable Premier League force?
-
Denmark inaugurates rare low-carbon hydrogen plant
-
Springboks back Ntlabakanye call-up despite doping probe
-
German plans to lower industrial power costs from January
-
Christian, Muslim Nigerians push back on threatened US strikes
-
Nigeria's Rivers United paired with African champions Pyramids
-
India women cricketers hail new era but challenges remain
-
'Heroic' worker praised as man charged over UK train stabbings
-
Bangladesh ex-PM Zia to contest elections: party
-
Tanzania president sworn in as opposition says hundreds killed in protests
-
India announces $5.75 million reward for women cricket World Cup winners
-
Stock markets rise on AI optimism
-
Spain regional leader resigns, a year after deadly floods
-
Video game creators fear AI could grab the controller
-
France threatens Shein ban if 'childlike' sex dolls reappear
-
International cricket returns to Faisalabad with Pakistan-South Africa ODIs
-
Afghan govt says quake kills 20, injures over 500
-
'We're all too rich,' says photo legend Martin Parr
-
Tanzania president inaugurated as opposition says hundreds dead
-
Shafali Verma: India's World Cup hero who disguised herself as boy
-
Most equity markets rise on lingering trader optimism
-
Asian markets rise on lingering trader optimism
-
Afghanistan quake kills 20, injures over 300: health ministry
-
India hails maiden women's World Cup cricket title as game-changer
-
As clock ticks down, Greece tries to clean up its act on waste
-
Local fabrics, fibres shine at eco-centred Lagos Fashion Week
-
Spalletti bidding to revive Juve and reputation ahead of Sporting visit in Champions League
-
Tanzania president to be inaugurated as opposition says hundreds dead
-
Bouanga brace as LAFC beats Austin 4-1 to advance in MLS Cup playoffs
-
'Golden age': Japan hails Yamamoto, Ohtani after Dodgers triumph
-
Thunder roll over Pelicans to remain NBA's lone unbeaten team
-
Hong Kong legislature now an 'echo chamber', four years after shake-up
-
Most Asian markets rise on lingering trader optimism
-
Andrew to lose his last military rank: defence minister
-
Trump's global tariffs to face challenge before Supreme Court
-
Barnstorming Bayern face acid test at reigning champions PSG
-
Alonso shaping new Real Madrid on Liverpool return
-
Half Yours favourite at Australia's 'race that stops a nation'
-
Tonga rugby league star has surgery after 'seizure' against NZ
-
Trent's return with Real Madrid reminds Liverpool of what they are missing
| RYCEF | 1.24% | 15.34 | $ | |
| RBGPF | -3.95% | 76 | $ | |
| SCS | -0.44% | 15.89 | $ | |
| RIO | -1.63% | 70.587 | $ | |
| CMSC | -0.13% | 23.718 | $ | |
| VOD | -5.29% | 11.445 | $ | |
| NGG | -0.49% | 74.88 | $ | |
| BP | -0.13% | 35.085 | $ | |
| GSK | -1.03% | 46.38 | $ | |
| RELX | -0.28% | 44.115 | $ | |
| BTI | 2.25% | 52.37 | $ | |
| BCE | -1.61% | 22.498 | $ | |
| BCC | -5.05% | 67.1 | $ | |
| AZN | -0.93% | 81.64 | $ | |
| JRI | -0.72% | 13.8 | $ | |
| CMSD | -0.33% | 23.91 | $ |
Japanese researchers test pioneering drug to regrow teeth
People with missing teeth may be able to grow new ones, say Japanese dentists testing a pioneering drug they hope will offer an alternative to dentures and implants.
Unlike reptiles and fish, which usually replace their fangs on a regular basis, it is widely accepted that humans and most other mammals only grow two sets of teeth.
But hidden underneath our gums are the dormant buds of a third generation, according to Katsu Takahashi, head of oral surgery at the Medical Research Institute Kitano Hospital in Osaka.
His team launched clinical trials at Kyoto University Hospital in October, administering an experimental medicine to adult test subjects that they say has the potential to jumpstart the growth of these concealed teeth.
It's a technology "completely new" to the world, Takahashi told AFP.
Prosthetic treatments used for teeth lost to decay, disease or injury are often seen as costly and invasive.
So "restoring natural teeth definitely has its advantages", said Takahashi, the project's lead researcher.
Tests on mice and ferrets suggest that blocking a protein called USAG-1 can awaken the third set, and the researchers have published lab photographs of regrown animal teeth.
In a study published last year, the team said their "antibody treatment in mice is effective for tooth regeneration and can be a breakthrough in treating tooth anomalies in humans".
- 'Only the beginning' -
For now, the dentists are prioritising the "dire" needs of patients with six or more permanent teeth missing from birth.
The hereditary condition is said to affect around 0.1 percent of people, who can have severe trouble chewing, and in Japan often spend most of their adolescence wearing a face mask to hide the wide gaps in their mouth, Takahashi said.
"This drug could be a game-changer for them," he added.
The drug is therefore aimed primarily at children, and the researchers want to make it available as early as 2030.
Angray Kang, a dentistry professor at Queen Mary University of London, only knows of one other team pursuing a similar objective of using antibodies to regrow or repair teeth.
"I would say that the Takahashi group is leading the way," the immunotechnology expert, who is not connected to the Japanese research, told AFP.
Takahashi's work is "exciting and worth pursuing", Kang said, in part because an antibody drug that targets a protein nearly identical to USAG-1 is already being used to treat osteoporosis.
"The race to regenerate human teeth is not a short sprint, but by analogy a set of back-to-back consecutive ultra-marathons," he said.
"This is only the beginning."
Chengfei Zhang, a clinical professor in endodontics at the University of Hong Kong, said Takahashi's method is "innovative and holds potential".
"The assertion that humans possess latent tooth buds capable of producing a third set of teeth is both revolutionary and controversial," he told AFP.
He also cautioned that "outcomes observed in animals do not always directly translate to humans".
The results of the animal experiments raise "questions about whether regenerated teeth could functionally and aesthetically replace missing teeth", Zhang added.
- 'Over the moon' -
A confident Takahashi argues that the location of a new tooth in a mouth can be controlled, if not pinpointed, by the drug injection site.
And if it grows in the wrong place, it can be moved through orthodontics or transplantation, he said.
No young patients with the congenital disorder are taking part in the first clinical trial, as the main objective is to test the drug's safety, rather than its effectiveness.
So for now, the participants are healthy adults who have lost at least one existing tooth.
And while tooth regeneration is not the express goal of the trial this time around, there is a slim chance that it could happen to subjects anyway, Takahashi said.
If so, the researchers will have confirmed that the drug can be effective for those with acquired toothlessness -- which would be a medical triumph.
"I would be over the moon if that happens," Takahashi said.
This could be particularly welcome news in Japan, which has the second-oldest population in the world.
Health ministry data shows more than 90 percent of people aged 75 or older in Japan have at least one tooth missing.
"Expectations are high that our technology can directly extend their healthy life expectancy," Takahashi said.
S.AbuJamous--SF-PST